how old are glp 1 drugs History of GLP-1 Medications What to Make of the

Respirology 23 (Dec), 10961097 (2018)

This broad receptor engagement profile means that Melanotan II simultaneously activates melanogenic pathways (MC1R on melanocytes), appetite and energy homeostasis circuits (MC3R/MC4R in hypothalamus), and exocrine gland function pathways (MC5R), making it essential for researchers to design appropriate controls and selective antagonists into experimental protocols to attribute observed effects to specific receptor subtypes

Ketone bodies as signaling metabolites

Given that some heterogeneity in efficacy and tolerability was observed across different agents, selection of a specific GLP-1 RA should be tailored to individual risk profiles and clinical goals

At 12 months, patients receiving exenatide had a mean improvement of 2.7 points, while the control group had a mean decline of 2.2 points, indicating a statistically significant difference of 4.9 points (95% CI, 0.3-9.4